Redox regulation of P-glycoprotein-mediated multidrug resistance in multicellular prostate tumor spheroids

International Journal of Cancer

Volumn 85, Issue 2, 2000, Pages 267-274

  Wartenberg, Maria ^a   Fischer, Kerstin ^a   Hescheler, Jürgen ^a   Sauer, Heinrich ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Department of Neurophysiology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DERIVATIVE; CYCLOSPORIN A; DOXORUBICIN; EBSELEN; GLYCERALDEHYDE; GLYCOPROTEIN P; HYDROGEN PEROXIDE; MENADIONE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; QUINIDINE; REACTIVE OXYGEN METABOLITE; VANADATE SODIUM; VERAPAMIL;

ARTICLE; CANCER RESISTANCE; CELL LEVEL; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MALE; MULTIDRUG RESISTANCE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCERALDEHYDE; HUMANS; HYDROGEN PEROXIDE; MALE; MICROTUBULE-ASSOCIATED PROTEINS; OXIDANTS; OXIDATION-REDUCTION; P-GLYCOPROTEIN; PHENOTYPE; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; VITAMIN K;

EID: 0034650814     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000115)85:2<267::AID-IJC19>3.0.CO;2-H     Document Type: Article

References (37)

1. ABRAHAM, I., CHIN, K.-V., GOTTESMAN, M.M., MAYO, J.K. and SAMPSON, K.E., Transfection of a mutant regulatory subunit gene of cAMP-dependent protein kinase A causes increased drug sensitivity and decreased expression of P-gylcoprotein. Exp. Cell Res., 189, 133-141 (1990).
2. BURDON, R.H., ALLIANGANA, D. and GILL, V., Endogenously generated active oxygen species and cellular glutathione levels in relation to BHK-21 cell proliferation. Free Radicals Res., 21, 121-133 (1994).
3. CORNWELL, M.M., PASTAN, I. and GOTTESMAN, M.M., Certain calcium channel blockers bind specifically to multidrug resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprolein. J. biol. Chem., 262, 2166-2170 (1987).
4. CVIJIC, M.E. and CHIN, K.V., Regulation of P-glycoprotein expression in cyclic AMP-dependent protein kinase mutants. Cell Growth Differentiation, 8, 1243-1247 (1997).
5. kip1 to the confluence-dependent resistance of HT29 human colon carcinoma cells. Int. J. Cancer, 77, 796-802 (1998).
6. DIMON-GADAL, S., GERBAUD, P., KERYER, G., ANDERSON, W., EVAIN-BRION, D. and RAYNAUD, F., In vitro effects of oxygen-derived free radicals on type I and type II cAMP-dependent protein kinases. J. biol. Chem., 273, 22833-22840 (1998).
7. GARRIDO, C., OTTAVI, P., FROMENTIN, A., HAMMANN, A., ARRIGO, A.P., CHAUFFERT, B. and MEHLEN, P., HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res., 57, 2661-2667 (1997).
8. HANDSHIN, J.C. and EPPENBERGER, U., Altered cellular ratio of type I and type II cyclic AMP-dependent protein kinase in human mammary tumors. FEBS Lett., 106, 301-304 (1979).
9. HU, Y.P., POURQUIER, P., DOIGNON, F., CROUZET, M. and ROBERT, J., Effects of modulators of multidrug resistance on the expression of the mdr1 gene on human KB cells in culture. Anticancer Drugs, 7, 738-744 (1996).
10. IKEGUCHI, M., TEETER, L.D., ECKERSBERG, T., GANAPATHI, R. and KUO, M.T., Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3/mdr1a reveal a negative element containing the AP-1 binding site. DNA Cell Biol., 10, 639-649 (1991).
11. KIM, S.H., PARK, J.I., CHUNG, B.S., KANG, C.D. and HIDAKA, H., Inhibition of mdr1 gene expression by H-87, a selective inhibitor of cAMP-dependent protein kinase. Cancer Lett., 74, 37-41 (1993).
12. KOBAYASHI, H., MAN, S., GRAHAM, C.H., KAPITAIN, S.J., TEICHER, B.A. and KERBEL, R.S., Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc. nat. Acad. Sci. (Wash.), 90, 3294-3298 (1993).
13. KOOMAGI, R., MATTERN, J. and VOLM, M., Up-regulation of resistance-related proteins in human lung tumors with poor vascularization Carcinogenesis, 18, 2905-2918 (1998).
14. KREJSA, C.M., NADLER, S.G., ESSELSTYN, J.M., KAVANAGH, T.J., LEDBETTER, J.A. and SCHIEVEN G.L., Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors. Redox independent activation of NF-kappa B. J. biol. Chem., 272, 11541-11549 (1997).
15. MILLER, W.R., WATSON, D.M.A., CHETTY, J.W. and ELTON, R.A., Tumour cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer. Breast Cancer Res. Treat., 26, 89-94 (1993).
16. MURRELL, G.A.C., FRANCIS, M.J.O. and BROMLEY, L., Modulation of fibroblast proliferation by free radicals. Biochem. J., 265, 659-665 (1990).
17. NAKSHATRI, H., BHAT-NAKSHATRI, P. and CURRIE, R.A., Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox. J. biol. Chem., 271, 28784-28791 (1996).
18. kip1 in osteoblast-like cells during differentiation with parathyroid hormone. Endocrinology 138, 1995-2004 (1997).
19. PARKS, D., BOLINGER, R. and MANN, K., Redox state regulates binding of p53 to sequence-specific DNA, but not to non-specific or mismatched DNA. Nucleic Acids Res., 25, 1289-1295 (1997).
20. PEREZ DE LEMA, G., ARRIBAS, I., PRIETO, A., PARRA, T., DE ARRIBA, G., RODRIGUEZ-PUYOL, D. and RODRIGUEZ-PUYOL, M., Cyclosporin A-induced hydrogen peroxide synthesis by cultured human mesangial cells is blocked by exogenous antioxidants. Life Sci., 62, 1745-1753 (1998).
21. PINKUS, R., WEINER, L.M. and DANIEL, V., Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. J. biol. Chem., 271, 13422-13429 (1996).
22. POWIS, G. and APPEL, P.J., Relationship of single-electron reduction potential of quinones to their reduction by flavoproteins. Biochem. Pharmacol., 29, 2567-2572 (1980).
23. RAYNAUD, F., EVAIN-BRION, D., GERBAUD, P., MARCIANO, D., GORIN, I., LIAPI, C. and ANDERSON, W.B., Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: possible role in psoriasis. Free Radicals Biol. Med., 22, 623-632 (1997).
24. SCALA, S., BUDILLON, A., ZHAN, Z., CHO-CHUNG, Y., JEFFERSON, J., TSOKOS, M. and BATES, S.E., Downregulation of MDR-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells. J. clin. Invest., 96, 1026-1034 (1995).
25. SEN, C.K. and PACKER, L., Antioxidant and redox regulation of gene transcription. FASEB J., 10, 709-720 (1996).
26. SIMON, S.M. and SCHINDLER, M., Cell biological mechanisms of multidrug resistance in tumors. Proc. nat. Acad. Sci. (Wash.), 91, 3497-3504 (1994).
27. kip1 on resistance of tumor cells to anticancer agents. Nature (Med.), 2, 1204-1210 (1996a).
28. ST. CROIX, B., RAK, J.W., KAPITAIN, S., SHEEHAN, C., GRAHAM, C.H. and KERBEL, RS., Reversal by hyaluronidase of adhesion-dependent multicellular drug resistance in mammary carcinoma cells. J. nat. Cancer Inst., 88, 1285-1296 (1996b).
29. STEIN, U., WALTHER, W. and SHOEMAKER, R.H., Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells. J. nat. Cancer Inst., 88, 1383-1392 (1996).
30. SZATROWSKI, T.P. and NATHAN, C.F., Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res., 51, 794-798 (1991).
31. TAKANISHI, K., MIYAZAKI, M., OHTSUKA, M. and NAKAJIMA, N., Inverse relationship between P-glycoprotein expression and its proliferative activity in hepatocellular carcinoma. Oncology, 54, 231-237 (1997).
32. THOR, H., SMITH, M.T., HARTZELL, P., BELLOMO, G., JEWELL, S.A. and ORRENIUS, S., The metabolism of menadione (2-methyl-1,4-naphtoquinine) by isolated hepatocytes. J. biol. Chem., 257, 12419-12425 (1982).
33. VOLM, M., Multidrug resistance and its reversal. Anticancer Res., 18, 2905-2918 (1998).
34. WARTENBERG, M., FREY, C., DIEDERSHAGEN, H., RITGEN, J., HESCHELER, J. and SAUER, H., Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids. Int. J. Cancer, 75, 855-863 (1998a).
35. WARTENBERG, M., HESCHELER, J., ACKER, H., DIEDERSHAGEN, H., and SAUER, H., Doxorubicin distribution in multicellular prostate cancer spheroids evaluated by confocal laser scanning microscopy and the "optical probe technique". Cytometry, 31, 137-145 (1998b).
36. YAMANE, Y., FURUICHI, M., SONG, R., VAN NGUYEN, T., MULCAHY, R.T., ISHIKAWA, T. and KUO, M.T., Expression of multidrug resistance protein/ GS-X pump and gamma-glutamylcysteine synthetase genes is regulated by oxidative stress. J. biol. Chem., 273, 31075-31085 (1998).
37. ZHOU, G. and KUO, M.T., Wild-type p53-mediated induction of rat MDR1b expression by the anticancer drug daunorubicin. J. biol. Chem., 273, 15387-15394 (1998).